Novartis has transformed its Global Health & Corporate Responsibility (GH&CR) organization. The change consolidates and streamlines expertise and resources to achieve a stronger focus on the areas where the company can have the greatest impact.
“This transformation is yet another demonstration of our unwavering commitment to place global health and corporate responsibility at the core of our business strategy,” said Patrice Matchaba, Group Head, Global Health & Corporate Responsibility.
The new GH&CR organization will oversee end-to-end execution of the company’s global health priorities, from discovery through development to implementation. It comprises four units:
Novartis Social Business is integrated into the GH&CR organization, bringing together the company’s flagship global health priorities (leprosy, malaria, Chagas disease and sickle cell disease) and its work in noncommunicable diseases. This team will continue to manage social business commercial operations.
The Novartis Foundation will refocus its efforts on how data, digital and artificial intelligence can transform global health.
Health System Strengthening and Innovation will serve as a center of excellence for capacity-building, partnerships, digital solutions and innovation in global health for patients in low-resource communities.
Corporate Responsibility Initiatives will encompass employee engagement and volunteering, as well as measurement and evaluation efforts, including impact valuation.
Earlier in 2019, Novartis strengthened its GH&CR governance, establishing an internal Environment, Social and Governance (ESG) Steering Committee, chaired by the CEO. The committee will oversee progress and speed up decision-making in key GH&CR areas.
Novartis Foundation sharpens its focus on digital, data and AI
The Novartis Foundation is sharpening its focus to concentrate fully on reimagining how data, digital and AI can transform global health. This new mandate builds on 40 years of striving for sustainable impact on health in low-income populations, most recently by focusing on leprosy elimination and cardiovascular health, in addition to digital health.
Novartis Foundation to focus fully on how digital, data and AI can transform global health.